Development of Extragenital Lichen Sclerosus in Malignant Melanoma Patients Treated With Ipilimumab in Combination With Nivolumab

Development of Extragenital Lichen Sclerosus in Malignant Melanoma Patients Treated With Ipilimumab in Combination With Nivolumab

The immune checkpoint inhibitors opened a new era for the treatment of melanoma. Nowadays, combined immune checkpoint inhibitors are administered to provide additive or synergistic effects on anti-melanoma immunity. The use of these drugs comes with serious adverse events related to excessive immune...

Full description

Bibliographic Details
Main Authors: S. Morteza Seyed Jafari, Laurence Feldmeyer, Robert E. Hunger
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
checkpoint inhibitors
extragenital lichen sclerosus et atrophicus
ipilimumab
malignant melanoma
metastatic
nivolumab
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.573527/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.573527/full

Similar Items